doi: 10.5281/zenodo.20511172
While anti-TNF therapy is a mainstay for Crohn's disease, other biological treatments such as ustekinumab, guselkumab, mirikizumab, and upadacitinib show promise for Ileal Crohn's disease with perianal involvement.